SSY Group Limited (HKG:2005)

SSY Group Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	4,379	4,165	5,773	6,463	6,434	5,357
Revenue Growth	5.12%	-27.85%	-10.67%	0.45%	20.11%	25.72%
Gross Profit Gross Profit Growth	1,813	1,731	2,908	3,620	3,568	3,170
Operating Income Operating Income Growth	669.96	595.52	1,363	1,638	1,422	1,006
Net Income Net Income Growth	507.45	470.64	1,061	1,319	1,123	785.53
Earnings Per Share EPS Growth	0.17	0.16	0.36	0.44	0.38	0.26
EPS Growth	8.82%	-55.19%	-19.09%	17.68%	45.16%	28.78%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Intravenous Infusion Solution and Others Intravenous Infusion Solution and Others Growth	4,167	3,970	5,585	6,301	6,265	5,209
Medical Materials Medical Materials Growth	420.33	377.42	405.07	387.45	350.84	356.62
Inter-Segment Inter-Segment Growth	-208.12	-182.24	-216.91	-225.82	-	-
Total Total Growth	4,379	4,165	5,773	6,463	6,434	5,357

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,891	1,795	1,407	1,616	1,714	1,700
Total Debt Total Debt Growth	4,049	4,015	3,640	3,374	3,209	3,108
Net Cash (Debt) Net Cash Growth	-2,158	-2,219	-2,232	-1,758	-1,495	-1,408
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.74	-0.76	-0.75	-0.59	-0.50	-0.46

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	983.92	635.04	491.03	925.75	733.69	695.63
Capital Expenditures CapEx Growth	-135.41	-141.06	-318.85	-436.87	-203.22	-169.7
Free Cash Flow Free Cash Flow Growth	848.51	493.98	172.18	488.87	530.47	525.93
Free Cash Flow Growth	71.77%	186.89%	-64.78%	-7.84%	0.86%	81.44%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	41.40%	41.56%	50.38%	56.01%	55.45%	59.18%
Operating Margin	15.30%	14.30%	23.61%	25.34%	22.10%	18.77%
Pretax Margin	13.75%	13.53%	22.20%	24.50%	21.75%	17.70%
Profit Margin	11.59%	11.30%	18.38%	20.40%	17.45%	14.66%
FCF Margin	19.38%	11.86%	2.98%	7.56%	8.24%	9.82%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.080	0.080	0.175	0.170	0.140	0.120
Dividend Per Share Growth	-41.38%	-54.29%	2.94%	21.43%	16.67%	20.00%
Dividend Yield	2.96%	2.92%	5.32%	3.90%	3.80%	3.63%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	15.46	17.47	9.95	11.12	11.41	15.34
Forward PE	13.50	11.38	7.50	9.55	9.51	10.52
P/FCF Ratio	9.20	16.64	61.32	30.00	24.15	22.91
PS Ratio	1.78	1.97	1.83	2.27	1.99	2.25

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error